FDA Approves Updated COVID-19 Vaccines for 2026-2027 Respiratory Season

AI-generated NewsSnap summary based on source reporting.
Published: 2026-08-28
Category: health
Source: Contagion Live

The U.S. Food and Drug Administration (FDA) has approved updated formulations of COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax for the 2026-2027 respiratory virus season. These vaccines are reformulated to target the JN.1-lineage XFG subvariant of SARS-CoV-2.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai